Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid to prevent postinflammatory hyperpigmentation after Q-switched Nd:YAG (532 nm) laser
TCTR20161010004Recruiting
- Sponsor
- Ramathibodi Hospital
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Post-inflammatory hyperpigmentation (PIH) comparing Oral tranexamic acid with Placebo (2 arms). Started Aug 2016; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on TCTR20161010004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161010004.